LeafNLP Demos
Back to explore

Report #2879880

Received Dec 29, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
FL
Recovered
Unknown
Vaccinated
Dec 17, 2025
Onset
Dec 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2Y015180—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; Patient was administered their second dose of GARDASIL 9 earlier than the recommended interval within the PI; This Spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history, past medications, and concomitant medications were not reported. On 19-Nov-2025, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) suspension for injection (dose, route of administration, anatomical location, lot number and expiry date were not reported) as prophylaxis. On 17-Dec-2025, the patient was vaccinated with the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) Suspension for injection in pre-filled syringe, 0.5 mL, total, (valid lot number: Y015180, expiration date reported and confirmed as 28-Jan-2027) as prophylaxis earlier than the recommended interval (Inappropriate schedule of product administration). No symptoms reported (no adverse event). Batch/Lot number is being requested and will be submitted if received.